Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

Health and Healthcare

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1320 Articles

Douglas A. McIntyre | Dec 17, 2007 at 10:49 AM EST

10 Turnarounds That Haven’t Turned Around: Pfizer (PFE, MRK, BMY, JNJ)

Early this week we are running a list of stocks that have been in a turnaround plan, yet the stocks…

Douglas A. McIntyre | Dec 7, 2007 at 12:12 PM EST

10 CEO’s That Need To Leave in 2008: James Tobin of Boston Scientific (BSX, BIIB, JNJ, ABT)

James Tobin, the CEO of Boston Scientific (NYSE:BSX) is likely to find himself in front of the shareholder firing squad…

Douglas A. McIntyre | Dec 5, 2007 at 4:15 AM EST

Media Digest 12/5/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, OPEC will probably keep oil output at current levels. Reuters writes that a goverment plan to help…

Douglas A. McIntyre | Dec 4, 2007 at 6:28 PM EST

Abbott (ABT) Stent Slowdown, Bad For Johnson & Johnson (JNJ) And Boston Scientific (BSX)

Abbott Labs (ABT) which just launched a new stent product, Xience V, has laid off 1,200 people because of slowness…

Douglas A. McIntyre | Nov 29, 2007 at 6:47 PM EST

Bad News For Boston Scientific (BSX) As Abbott (ABT) Moves Closer To Stent Approval

Abbot Labs (ABT) is trying to get into the stent business. The market has been dominated by Boston Scientific (BSX)…

Douglas A. McIntyre | Nov 12, 2007 at 6:45 AM EST

As Doctors Renew Interest In Stents, Boston Scientific (BSX) May Get A Break

Several studies which showed that stents could cause blood clotting in the heart have done significant damage to the revenue…

Douglas A. McIntyre | Nov 12, 2007 at 4:24 AM EST

Media Digest 11/12/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, BHP Billiton (BHP) will not sell its petroleum division, as had been rumored, to finance a bid…

Douglas A. McIntyre | Nov 8, 2007 at 12:08 PM EST

Defensive Stocks Show Rotation Out of Tech (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

The markets haven’t fallen apart after yesterday’s 360 point dive on the DJIA, but we are still trading a tad…

Douglas A. McIntyre | Nov 5, 2007 at 5:54 AM EST

Boston Scientific (BSX): Saving Itself Through Auctioning Off Pieces

Boston Scientific (BSX) did it shareholders a terrible disservice buy buying Guidant in a bidding war with Johnson & Johnson.…

Douglas A. McIntyre | Nov 1, 2007 at 12:30 PM EDT

Defensive Stocks Show No Panic Rotation (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

With the markets down so much today on the financial stock fallout after the Citi downgrade/concern and with oil stocks…

Douglas A. McIntyre | Oct 21, 2007 at 10:17 AM EDT

For Boston Scientific And JNJ, The Stent Stats Get Worse

"William O’Neill, dean of clinical affairs at University of Miami’sMiller School of Medicine, says stent-patient traffic is beginning topick up…

Douglas A. McIntyre | Oct 16, 2007 at 9:07 AM EDT

Interpreting Amgen Sales From J&J’s PROCRIT (AMGN, JNJ)

Shares of Amgen Inc. (NASDAQ:AMGN) are under bit of pressure this morning, although not from any direct news from the…

Douglas A. McIntyre | Oct 16, 2007 at 7:03 AM EDT

Johnson & Johnson’s (JNJ) Good Quarter

Johnson & Johnson (JNJ) announced third-quarter sales of $15.0 billion, an increase of 12.7% as compared to the third quarter…

Douglas A. McIntyre | Oct 11, 2007 at 5:57 AM EDT

As Stent Business Falls Apart, Field Gets More Crowded

Medtronic (MDT) got the FDA to approve its new drug-coated stent called the Endeavor. The agency did have some concerns…

Douglas A. McIntyre | Oct 6, 2007 at 3:10 PM EDT

Medtronic (MDT): The Stent Business Gets Worse

Medtronic (MDT) has decided to get into the stent business, making the little mesh tubes that keep arteries open. It…

1 … 84 85 86 87 88 89

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

10 Turnarounds That Haven’t Turned Around: Pfizer (PFE, MRK, BMY, JNJ)

10 CEO’s That Need To Leave in 2008: James Tobin of Boston Scientific (BSX, BIIB, JNJ, ABT)

Media Digest 12/5/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Abbott (ABT) Stent Slowdown, Bad For Johnson & Johnson (JNJ) And Boston Scientific (BSX)

Bad News For Boston Scientific (BSX) As Abbott (ABT) Moves Closer To Stent Approval

As Doctors Renew Interest In Stents, Boston Scientific (BSX) May Get A Break

Media Digest 11/12/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Defensive Stocks Show Rotation Out of Tech (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

Boston Scientific (BSX): Saving Itself Through Auctioning Off Pieces

Defensive Stocks Show No Panic Rotation (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

For Boston Scientific And JNJ, The Stent Stats Get Worse

Interpreting Amgen Sales From J&J’s PROCRIT (AMGN, JNJ)

Johnson & Johnson’s (JNJ) Good Quarter

As Stent Business Falls Apart, Field Gets More Crowded

Medtronic (MDT): The Stent Business Gets Worse

Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

Retire on Dividends Alone: The Super-High-Yield Stocks Boomers Are Buying and Never Selling

Buy Alphabet at $350 Because Wall Street’s Former Fear is Now Officially Dead

Meta vs Pinterest: The Better Stock For Long-Term Investors

He Cashed Out His Bitcoin at 68 to Play It Safe. Medicare Read It as a Six-Figure Raise.

Is Your Bicentennial Quarter Worth $19,200 or 25 Cents? Here's How to Tell in 10 Seconds

Retire on Dividends Alone: The Super-High-Yield Stocks Boomers Are Buying and Never Selling

Buy Alphabet at $350 Because Wall Street’s Former Fear is Now Officially Dead

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

10 Turnarounds That Haven’t Turned Around: Pfizer (PFE, MRK, BMY, JNJ)

10 CEO’s That Need To Leave in 2008: James Tobin of Boston Scientific (BSX, BIIB, JNJ, ABT)

Media Digest 12/5/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Abbott (ABT) Stent Slowdown, Bad For Johnson & Johnson (JNJ) And Boston Scientific (BSX)

Bad News For Boston Scientific (BSX) As Abbott (ABT) Moves Closer To Stent Approval

As Doctors Renew Interest In Stents, Boston Scientific (BSX) May Get A Break

Media Digest 11/12/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Defensive Stocks Show Rotation Out of Tech (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

Boston Scientific (BSX): Saving Itself Through Auctioning Off Pieces

Defensive Stocks Show No Panic Rotation (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

For Boston Scientific And JNJ, The Stent Stats Get Worse

Interpreting Amgen Sales From J&J’s PROCRIT (AMGN, JNJ)

Johnson & Johnson’s (JNJ) Good Quarter

As Stent Business Falls Apart, Field Gets More Crowded

Medtronic (MDT): The Stent Business Gets Worse

Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

Retire on Dividends Alone: The Super-High-Yield Stocks Boomers Are Buying and Never Selling

Buy Alphabet at $350 Because Wall Street’s Former Fear is Now Officially Dead

Meta vs Pinterest: The Better Stock For Long-Term Investors

Featured Reads

He Cashed Out His Bitcoin at 68 to Play It Safe. Medicare Read It as a Six-Figure Raise.

Is Your Bicentennial Quarter Worth $19,200 or 25 Cents? Here's How to Tell in 10 Seconds